Focus on Diabetes Care

Back to articles

Hypoglycemia risk increases when a DPP-4 inhibitor is given with a sulfonylurea

KEY POINT

The risk of hypoglycemia increases substantially when a dipeptidyl peptidase-4 (DPP-4) inhibitor is given with a sulfonylurea, emphasizing the need to reduce the sulfonylurea dose and educate patients about this increased risk when combination therapy is given.